CN112940520A - 一类具有细胞器定位性质的荧光染料在细胞器成像中的应用 - Google Patents
一类具有细胞器定位性质的荧光染料在细胞器成像中的应用 Download PDFInfo
- Publication number
- CN112940520A CN112940520A CN201911257415.6A CN201911257415A CN112940520A CN 112940520 A CN112940520 A CN 112940520A CN 201911257415 A CN201911257415 A CN 201911257415A CN 112940520 A CN112940520 A CN 112940520A
- Authority
- CN
- China
- Prior art keywords
- organelle
- imaging
- dye
- solvent
- fluorescent dye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003463 organelle Anatomy 0.000 title claims abstract description 46
- 238000003384 imaging method Methods 0.000 title claims abstract description 26
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 20
- 239000000975 dye Substances 0.000 claims abstract description 28
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims abstract description 23
- 239000002904 solvent Substances 0.000 claims description 42
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 230000015572 biosynthetic process Effects 0.000 claims description 23
- 238000003786 synthesis reaction Methods 0.000 claims description 23
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 10
- 238000010898 silica gel chromatography Methods 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 230000030589 organelle localization Effects 0.000 claims description 7
- -1 specifically H Chemical group 0.000 claims description 7
- 125000001424 substituent group Chemical group 0.000 claims description 7
- 238000004440 column chromatography Methods 0.000 claims description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Substances C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 6
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical class O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- JYWKEVKEKOTYEX-UHFFFAOYSA-N 2,6-dibromo-4-chloroiminocyclohexa-2,5-dien-1-one Chemical compound ClN=C1C=C(Br)C(=O)C(Br)=C1 JYWKEVKEKOTYEX-UHFFFAOYSA-N 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 4
- 239000001632 sodium acetate Substances 0.000 claims description 4
- 235000017281 sodium acetate Nutrition 0.000 claims description 4
- JJCRDRWLOVYESJ-UHFFFAOYSA-N CC1N(C(C)=S)C2=CCCCC2C1(C)C Chemical compound CC1N(C(C)=S)C2=CCCCC2C1(C)C JJCRDRWLOVYESJ-UHFFFAOYSA-N 0.000 claims description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- 229910006069 SO3H Inorganic materials 0.000 claims description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims description 2
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 abstract description 16
- 239000011159 matrix material Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 27
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- 238000001819 mass spectrum Methods 0.000 description 12
- 239000007787 solid Substances 0.000 description 12
- 238000007689 inspection Methods 0.000 description 7
- 239000012452 mother liquor Substances 0.000 description 7
- 238000001228 spectrum Methods 0.000 description 7
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 206010008342 Cervix carcinoma Diseases 0.000 description 5
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 5
- 201000010881 cervical cancer Diseases 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- 238000000799 fluorescence microscopy Methods 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 238000005286 illumination Methods 0.000 description 4
- 238000000386 microscopy Methods 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000010226 confocal imaging Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- KLMIYOSCYBTUJO-UHFFFAOYSA-N CC1N(CCCC(C)=S)C2=CCCCC2C1(C)C Chemical compound CC1N(CCCC(C)=S)C2=CCCCC2C1(C)C KLMIYOSCYBTUJO-UHFFFAOYSA-N 0.000 description 2
- OXMKSBSTSDSJFM-UHFFFAOYSA-N CCCCN1C2=CC=CCC2C(C)(C)C1C Chemical compound CCCCN1C2=CC=CCC2C(C)(C)C1C OXMKSBSTSDSJFM-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000002211 ultraviolet spectrum Methods 0.000 description 2
- KMWHQYDMBYABKL-UHFFFAOYSA-N 1-iodohexadecane Chemical compound CCCCCCCCCCCCCCCCI KMWHQYDMBYABKL-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- IVWSGOOPQGMALJ-UHFFFAOYSA-N 2,3,3-trimethyl-1,2-dihydroindole Chemical compound C1=CC=C2C(C)(C)C(C)NC2=C1 IVWSGOOPQGMALJ-UHFFFAOYSA-N 0.000 description 1
- HYMGVJCGCUPQAZ-UHFFFAOYSA-N CC1N(CCCCBr)C2=CC=CCC2C1(C)C Chemical compound CC1N(CCCCBr)C2=CC=CCC2C1(C)C HYMGVJCGCUPQAZ-UHFFFAOYSA-N 0.000 description 1
- QERNGWQOHWWKEH-UHFFFAOYSA-N CC1N(CCCCC(C)=S)C2=CCCCC2C1(C)C Chemical compound CC1N(CCCCC(C)=S)C2=CCCCC2C1(C)C QERNGWQOHWWKEH-UHFFFAOYSA-N 0.000 description 1
- HPFQSCYCILZILN-UHFFFAOYSA-N CCCCC1(C(C)(C)C(C)N2C(C)=S)C2=CCCC1 Chemical compound CCCCC1(C(C)(C)C(C)N2C(C)=S)C2=CCCC1 HPFQSCYCILZILN-UHFFFAOYSA-N 0.000 description 1
- HYFBLSZDIFFHLZ-UHFFFAOYSA-N CCCCCCCCCCCCCCCCN1C2=CC=CCC2C(C)(C)C1C Chemical compound CCCCCCCCCCCCCCCCN1C2=CC=CCC2C(C)(C)C1C HYFBLSZDIFFHLZ-UHFFFAOYSA-N 0.000 description 1
- PFKDLAAZADVCEZ-UHFFFAOYSA-N CCCCCCCCCCCCCCCCN1C2=CCCCC2C(C)(C)C1C Chemical compound CCCCCCCCCCCCCCCCN1C2=CCCCC2C(C)(C)C1C PFKDLAAZADVCEZ-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000010857 super resolution fluorescence microscopy Methods 0.000 description 1
- 238000010869 super-resolution microscopy Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/10—The polymethine chain containing an even number of >CH- groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
- C09K2211/1037—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with sulfur
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Materials Engineering (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Indole Compounds (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
本发明涉及一类具有细胞器定位性质的荧光染料在细胞器成像中的应用,该类染料的结构特征在于带有细胞器定位基团的具有分子内开关的五甲川菁。具有分子内开关的五甲川菁荧光团光稳定性强、亮度高,通过向荧光团母体上引入细胞器定位基团进行细胞器定位,这类染料可实现对活细胞细胞器的长时间观察与超分辨成像。
Description
技术领域
本发明属于荧光成像技术领域,具体涉及一类具有细胞器定位性质的荧光染料在细胞器成像中的应用。
背景技术
自荧光检测技术出现以来,生命科学和基础医学领域的大量工作相继开展,着力于研究细胞内的各项生命活动。细胞器是细胞的重要结构单元,细胞内复杂的生命活动依赖各细胞器密切配合、共同完成。细胞器形态结构的改变、细胞器之间相互作用的开展及细胞器内部微环境的改变都意味着不同的生理活动的发生,荧光显微成像技术作为原位、无损追踪这类动态生命活动的主要工具在这一领域应用极为广泛。近些年来超分辨荧光显微技术的发展,使得对细胞器长时间动态的观察愈加细致,也对细胞器定位荧光染料提出了更高要求。
为了实现更高的定位精度,超分辨显微成像技术要求单位时间内获得的光子数更多,这就对染料亮度提出了更高要求。此外,相比于传统的共聚焦荧光显微镜,超分辨显微镜所使用的激光器强度亦大幅度提高,因此更高光稳定性的染料不仅是实现高分辨成像的必要条件,也是满足长时间动态观察生命过程的必要条件。遗憾的是,目前大部分细胞器定位染料在亮度和光稳定性上都不足以满足长时间超分辨成像的要求。
花菁类染料是目前已知的吸光度最高,亮度最高的一类染料,在超分辨成像领域应用最为广泛。基于花菁类染料开发一类细胞器定位的荧光染料,是实现超分辨成像条件下长时间动态观察细胞器的有效途径。
发明内容
本发明涉及一类具有细胞器定位性质的荧光染料在细胞器成像中的应用,应用于细胞器成像中;该类染料为具有分子内开关的五甲川菁类荧光染料。此开关在酸性至碱性的较宽pH范围内均处于闭环状态,保护分子免于受到光漂白。成像条件下,分子可在质子、盐离子、激光、蛋白质及细胞内其他物质的作用下开环,开环分子亮度高、稳定性强,可实现对细胞器的长时间动态观察。
本发明公开了一类具有细胞器定位性质的荧光染料,适用于活细胞细胞器成像的荧光染料,是以五甲川菁染料为结构单元,其结构式如下所示,
其中,X、Y为是相同或不同的取代基,具体为H、COOH、SO3H或SO3 -中的任何一种基团;
Z为R1,R1SH,R1OH,R1COOH,R1PPh3 +,R1具体为H、CmH2m+1、CmH2m、 CmH2m-1、CmH2m-3中的任一基团,或其带有单个或多个二级取代基团的衍生结构; m是1~20之间的整数;
同时,本发明还提供了具有细胞器定位性质的荧光染料的一般合成方法,合成步骤如下:
具体合成步骤为:
步骤一:半菁的合成
将Y、Z取代基修饰的2,3,3-三甲基三氢吲哚与丙二醛衍生物按摩尔比 1:1-1:1.1置于圆底烧瓶中,加入溶剂乙酸酐,升温至90-110℃反应1-5小时;减压除去溶剂,硅胶柱层析得到红棕色产物半菁;
步骤二:X取代基修饰的N-硫乙酰烷基-2,3,3-三甲基三氢吲哚的合成
将X修饰的N-溴烷基-2,3,3-三甲基三氢吲哚和硫代乙酸钾按摩尔比 1:1-10溶于N,N-二甲基乙酰胺中,25-90℃下搅拌1-12小时;减压除去溶剂,得到产物待用;
步骤三:花菁的合成
将步骤一得到的半菁,步骤二得到的X取代基修饰的N-硫乙酰烷基-2,3,3- 三甲基三氢吲哚按及醋酸钠按摩尔比1:1-1.1:1-10置于圆底烧瓶中,加入溶剂醋酸酐,升温至90-110℃反应1-5小时;减压除去溶剂,硅胶柱层析得到蓝色产物花菁;
步骤四:具有分子内开关的五甲川菁染料的合成
将步骤三得到的菁染料与无水碳酸钾按摩尔比1:1-5加入圆底烧瓶中,向其中加入溶剂甲醇,室温下搅拌反应0.5-2小时;减压除去溶剂,色谱柱层析得到浅黄色产物即具有细胞器定位性质的荧光染料。
上述这类染料能够应用于细胞器的荧光成像,并作为探针用于荧光传感。
本发明具有以下特征:
这类细胞器成像染料具有合成原料低价、方法简单且易于衍生等优点。
这类细胞器成像染料可以实现准确地细胞器定位,并对细胞器状态进行长时间的追踪与观察。
这类细胞器染料光稳定性强,细胞内超分辨荧光成像条件下,相比于不加此修饰的五甲川菁染料,荧光强度降低至60%可成像帧数提高了九倍。
这类细胞器染料对细胞器内质子环境、蛋白质及离子等有亮-暗态的转变,可作为探针用于细胞器内微环境的检测。
附图说明
图1:为实施例1中中间体花菁CySA-4C的核磁氢谱;
图2:为实施例1中中间体花菁CySA-4C的核磁碳谱;
图3:为实施例1中目标化合物CyS-4C的核磁氢谱;
图4:为实施例1中目标化合物CyS-4C在不同溶剂中的紫外可见吸收图谱;
图5:为实施例1中目标化合物CyS-4C在不同溶剂中的荧光发射图谱;
图6:为实施例1中目标化合物CyS-4C染色的人宫颈癌细胞(HeLa)线粒体的结构光照明超分辨显微成像(SIM);
图7:为实施例5中目标化合物CySMB-3C染色的人宫颈癌细胞(HeLa)细胞膜的共聚焦成像。
具体实施方式
实施例1
染料CyS-4C的合成
中间体半菁的合成路线和产物结构如下:
称取N-甲基-2,3,3-三氢吲哚(300mg,1mmol)与丙二醛衍生物(284mg,1mmol)置于单口瓶中,加入溶剂乙酸酐3mL,升温至90℃搅拌2小时。减压除去溶剂,硅胶柱层析 (二氯甲烷/甲醇=50/1,V/V)得红棕色固体181mg,产率60%。
其高分辨质谱数据如下:
HRMS(ESI):m/z:[M]+:计算值:345.1961,实验值:345.1964。
经检测,其结构如上式示。
中间体N-硫乙酰丁基-2,3,3-三甲基三氢吲哚的合成
称取化合物N-(4-溴丁基)-2,3,3-三甲基三氢吲哚(150mg,0,4mmol),硫代乙酸钾(46 mg,0.4mmol)置于圆底烧瓶中,加入溶剂N,N-二甲基甲酰胺2mL,室温下搅拌12小时,减压蒸去溶剂直接用于下一步。
其高分辨质谱数据如下:
HRMS(ESI):m/z:[M]+:计算值:290.1573,实验值:290.1576。
经检测,其结构如上式示。
中间体花菁CySA-4C的合成
称取化合物N-硫乙酰丁基-2,3,3-三甲基三氢吲哚(150mg,0.41mmol),步骤一合成的半菁(140mg,0.41mmol),乙酸钠(45mg,0.54mmol)置于圆底烧瓶中,加入溶剂醋酸酐5mL,升温至90℃搅拌1小时。减压争取溶剂,硅胶柱层析(二氯甲烷/甲醇=50/1, V/V)得蓝色固体104mg,产率44%。
其高分辨质谱数据如下:
HRMS(ESI):m/z:[M]+:计算值:499.2778,实验值:499.2743。
其核磁氢谱如图1所示,具体数据如下:
1H NMR(400MHz,CDCl3)δ8.10(t,J=12.7小时z,2H),7.29(t,J=6.5小时z,4H),7.14 (t,J=7.4小时z,2H),7.06(dd,J=15.0,8.0小时z,2H),6.76(t,J=12.3小时z,1H),6.24(dd,J =13.2,10.0小时z,2H),4.09–4.00(m,2H),3.63(s,3H),2.88(t,J=6.7小时z,2H),2.24(s, 3H),1.81(d,J=6.9小时z,2H),1.70(s,6H),1.68(s,6H),1.18(t,J=7.1小时z,2H).
其核磁碳谱如图2所示,具体数据如下:
13C NMR(101MHz,CDCl3)δ194.84,172.62,171.88,152.78,141.66,140.94,140.29, 140.05,127.63,125.32,124.24,124.13,121.38,121.24,109.61,109.55,102.98,102.63,59.38, 48.46,48.43,42.96,29.75,27.47,27.23,27.03,25.95,25.24,13.21.
经检测,其结构如上式示。
目标化合物CyS-4C的合成
称取上一步获得的花菁染料(60mg,0.1mmol),碳酸钾(15mg,0.1mmol)置于圆底烧瓶中,加入溶剂甲醇2mL,室温下搅拌20min。减压蒸去溶剂,碱性氧化铝柱层析(二氯甲烷/甲醇=15/1,V/V)得浅黄色固体10mg,产率17%。
其高分辨质谱数据如下:
HRMS(ESI):m/z:[M]+:计算值:457.2672,实验值:457.2610。
其核磁氢谱见图3,具体数据如下:
1H NMR(400MHz,CDCl3)δ8.15(t,J=12.8小时z,2H),7.28(dd,J=13.8,5.8小时z,4H),7.13(t,J=7.3小时z,2H),7.05(dd,J=15.1,7.9小时z,2H),6.79(t,J=12.2小时z,1H), 6.37(dd,J=16.6,13.9小时z,2H),4.09(s,2H),3.63(s,3H),2.69(t,J=6.2小时z,2H),1.84(s, 4H),1.70(s,6H),1.66(s,6H).
经检测,其结构如上式示。
将本实施例得到的化合物CyS-4C溶解于二甲基亚砜溶液中,配制成不同染料的2mM母液,根据需要制配成不同浓度测试溶液,对其不同溶剂中的光谱、对离子及pH等的响应,活细胞长时间超分辨成像性质进行检测。
CyS-4C在多种溶剂中的光谱测试。取7.5μL母液,加入3mL溶剂中,配制成5μM的荧光探针测试液,并进行紫外和荧光光谱的测试。
CyS-4C对活细胞的结构光照明显微成像(SIM)。取1μL母液置于1mL人宫颈癌细胞(HeLa)培养液中,培养箱中孵育60min,随后用于结构光照明显微成像。
实施例2
化合物CySMito-3C的合成
中间体半菁的合成
称取化合物N-硫乙酰丙基-2,3,3-三甲基三氢吲哚(200mg,0.55mmol),丙二醛衍生物(180mg,0.63mmol)置于圆底烧瓶中,加入溶剂醋酸酐,升温至 110℃搅拌1小时,减压蒸去溶剂,硅胶柱层析得红棕色固体60mg,产率20%。
其高分辨质谱数据如下:
HRMS(ESI):m/z:[M]+:计算值:405.1995,实验值:405.2004.
经检验,其结构如上式所示。
中间体N-(4-三苯基膦)丁基-2,3,3-三甲基三氢吲哚的合成
称取化合物N-(4-溴丙基)-2,3,3-三甲基三氢吲哚(100mg,0.27mmol),三苯基膦(702mg,2.7mmol)置于圆底烧瓶中,加入溶剂乙腈2mL,90℃搅拌过夜。旋干反应液,用正己烷分散残余液,四氢呋喃洗涤,抽滤得肉粉色固体140mg,产率99%。
其高分辨质谱数据如下:
HRMS(ESI):m/z:[M]2+:计算值:446.2842,实验值:223.1419。
其核磁数据如下:
1H NMR(400MHz,DMSO-d6)δ8.00(s,1H),7.90(d,J=6.7Hz,3H),7.87– 7.73(m,12H),7.62(s,3H),7.57(s,1H),4.56(s,2H),3.77(s,2H),3.60(s,2H),2.83 (s,3H),2.10(s,2H),1.49(s,6H).
经检测,其结构如上式示。
中间体花菁的合成
称取化合物N-(4-三苯基膦)丁基-2,3,3-三甲基三氢吲哚(97mg,0.20 mmol),上一步制得的半菁(75mg,0.15mmol)置于圆底烧瓶中,向其中加入溶剂醋酸酐5mL,升温至110℃搅拌1小时。减压蒸去溶剂,碱性氧化铝柱层析(二氯甲烷/甲醇=15/1,V/V)得蓝色固体20mg,产率10%。
其高分辨质谱数据如下:
HRMS(ESI):m/z:[M]2+:计算值:788.3918,实验值:394.1953.
经检验,其结构如上式所示。
目标化合物CySMito-3C的合成
CySMito-3C
称取上一步获得的花菁染料(60mg,0.1mmol),碳酸钾(75mg,0.5mmol)置于圆底烧瓶中,加入溶剂甲醇2mL,50℃搅拌0.5h。减压蒸去溶剂,碱性氧化铝柱层析(二氯甲烷/甲醇=15/1,V/V)得浅黄色固体10mg,产率17%。
其高分辨质谱数据如下:
HRMS(ESI):m/z:[M]+:计算值:746.3813,实验值:746.3901.
经检验,其结构如上式所示。
实施例3
化合物CySMB-3C的合成
中间体半菁的合成
称取化合物N-硫乙酰丙基-2,3,3-三甲基三氢吲哚(200mg,0.55mmol),丙二醛衍生物(180mg,0.63mmol)置于圆底烧瓶中,加入溶剂醋酸酐,升温至 110℃搅拌2小时,减压蒸去溶剂,硅胶柱层析得红棕色固体60mg,产率20%。
其高分辨质谱数据如下:
HRMS(ESI):m/z:[M]+:计算值:405.1995,实验值:405.2004.
经检验,其结构如上式所示。
中间体N-十六烷基-2,3,3-三甲基三氢吲哚的合成
取化合物2,3,3-三甲基三氢吲哚(550μL,3mmol),碘十六烷(1.3g,3mmol) 置于密封管中,加热至90℃搅拌48小时。充分冷却反应液,将固体分散于正己烷中,抽滤得紫色蜡状固体1.36g,产率38%。
其高分辨质谱数据如下:
HRMS(ESI):m/z:[M]+:计算值:384.3625,实验值:384.3668。
其核磁数据如下:
1H NMR(400MHz,DMSO-d6)δ7.99–7.95(m,1H),7.84(dd,J=5.9,2.7Hz, 1H),7.63(dd,J=5.1,3.7Hz,2H),4.48–4.39(m,2H),2.83(s,3H),1.88–1.77(m, 2H),1.53(s,6H),1.45–1.36(m,2H),1.34–1.19(m,24H),0.85(t,J=6.8Hz,3H).
经检验,其结构如上式所示。
中间体花菁的合成
称取化合物N-十六烷基-2,3,3-三甲基三氢吲哚(97mg,0.20mmol),上一步制得的半菁(75mg,0.15mmol)置于圆底烧瓶中,向其中加入溶剂醋酸酐5 mL,升温至90℃搅拌2小时。减压蒸去溶剂,硅胶柱层析(二氯甲烷/甲醇= 15/1,V/V)得蓝色固体20mg,产率10%。
其高分辨质谱数据如下:
HRMS(ESI):m/z:[M]+:计算值:695.4969,实验值:695.4979
经检验,其结构如上式所示。
目标化合物CySMB-3C的合成
CySMB-3C
称取上一步获得的花菁染料(60mg,0.1mmol),碳酸钾(15mg,0.1mmol) 置于圆底烧瓶中,加入溶剂甲醇2mL,室温搅拌2h。减压蒸去溶剂,碱性氧化铝柱层析(二氯甲烷/甲醇=15/1,V/V)得浅黄色固体10mg,产率17%。
其高分辨质谱数据如下:
HRMS(ESI):m/z:[M+H]+:计算值:653.4863,实验值:653.4872.
经检验,其结构如上式所示。
实施例4
实施例1中制得的化合物CyS-4C在多种溶剂中的光谱测试。取7.5μL母液,加入3mL溶剂中,配制成5μM的荧光探针测试液,并进行紫外和荧光光谱的测试。
如图4、图5所示,在有机溶剂中,该化合物的最大吸收位于645nm左右,荧光位于675nm左右。在水中,该化合物出现明显的H聚集,荧光淬灭。在PBS中,该化合物出现无序聚集,荧光淬灭。
实施例5
实施例1中制得的化合物CyS-4C对活细胞的结构光照明显微成像(SIM)。取1μL母液置于1mL人宫颈癌细胞(HeLa)培养液中,培养箱中孵育60min,随后用于结构光照明显微成像。
如图6所示,HeLa细胞的线粒体轮廓明确,线粒体嵴清晰可见。化合物CyS-4C可实现活细胞线粒体超分辨成像。
实施例6
实施例3制得的化合物CySMB-3C的活细胞共聚焦成像实验。取1μL母液置于1mL人宫颈癌细胞(HeLa)培养液中,培养箱中孵育60min,随后用于共聚焦成像。
如图7所示,在共聚焦条件下该化合物的开环形式主要分布在细胞膜表面,培养基中基本无开环分子,成像背景低、对比度高。
Claims (5)
2.根据权利要求1所述具有细胞器定位性质的荧光染料在细胞器成像中的应用,其特征在于:所述具有细胞器定位性质的荧光染料通过以下方法制备得到:
步骤一:半菁的合成
将Y、Z取代基修饰的2,3,3-三甲基三氢吲哚与丙二醛衍生物按摩尔比1:1-1:1.1置于圆底烧瓶中,加入溶剂乙酸酐,升温至90-110℃反应1-5小时;减压除去溶剂,硅胶柱层析得到红棕色产物半菁;
步骤二:X取代基修饰的N-硫乙酰烷基-2,3,3-三甲基三氢吲哚的合成
将X修饰的N-溴烷基-2,3,3-三甲基三氢吲哚和硫代乙酸钾溶于N,N-二甲基乙酰胺中,25-90℃下搅拌1-12小时;减压除去溶剂,得到产物待用;
步骤三:花菁的合成
将步骤一得到的半菁,步骤二得到的X取代基修饰的N-硫乙酰烷基-2,3,3-三甲基三氢吲哚按及醋酸钠置于圆底烧瓶中,加入溶剂醋酸酐,升温至90-110℃反应1-5小时;减压除去溶剂,硅胶柱层析得到蓝色产物花菁;
步骤四:具有分子内开关的五甲川菁染料的合成
将步骤三得到的菁染料与无水碳酸钾加入圆底烧瓶中,向其中加入溶剂甲醇,室温下搅拌反应0.5-2小时;减压除去溶剂,色谱柱层析得到浅黄色产物即具有细胞器定位性质的荧光染料。
3.根据权利要求2所述具有细胞器定位性质的荧光染料在细胞器成像中的应用,其特征在于:所述步骤二中X修饰的N-溴烷基-2,3,3-三甲基三氢吲哚和硫代乙酸钾摩尔比为1:1-10。
4.根据权利要求2所述具有细胞器定位性质的荧光染料在细胞器成像中的应用,其特征在于:所述步骤三中半菁、X取代基修饰的N-硫乙酰烷基-2,3,3-三甲基三氢吲哚及醋酸钠摩尔比为1:1-1.1:1-10。
5.根据权利要求2所述具有细胞器定位性质的荧光染料在细胞器成像中的应用,其特征在于:所述步骤四中花菁染料与无水碳酸钾摩尔比为1:1-5。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911257415.6A CN112940520B (zh) | 2019-12-10 | 2019-12-10 | 一类具有细胞器定位性质的荧光染料在细胞器成像中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911257415.6A CN112940520B (zh) | 2019-12-10 | 2019-12-10 | 一类具有细胞器定位性质的荧光染料在细胞器成像中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112940520A true CN112940520A (zh) | 2021-06-11 |
CN112940520B CN112940520B (zh) | 2023-03-31 |
Family
ID=76225312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911257415.6A Active CN112940520B (zh) | 2019-12-10 | 2019-12-10 | 一类具有细胞器定位性质的荧光染料在细胞器成像中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112940520B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000159774A (ja) * | 1998-11-25 | 2000-06-13 | Fuji Photo Film Co Ltd | エレクトロクロミツク化合物及び該化合物を含むエレクトロクロミツク材料 |
CN101787218A (zh) * | 2010-01-15 | 2010-07-28 | 大连理工大学 | 一类共轭链上β-位氮取代五甲川菁类荧光染料 |
CN103146220A (zh) * | 2012-10-25 | 2013-06-12 | 西安电子科技大学 | 对称五甲川菁染料及其在分子影像中的应用 |
-
2019
- 2019-12-10 CN CN201911257415.6A patent/CN112940520B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000159774A (ja) * | 1998-11-25 | 2000-06-13 | Fuji Photo Film Co Ltd | エレクトロクロミツク化合物及び該化合物を含むエレクトロクロミツク材料 |
CN101787218A (zh) * | 2010-01-15 | 2010-07-28 | 大连理工大学 | 一类共轭链上β-位氮取代五甲川菁类荧光染料 |
CN103146220A (zh) * | 2012-10-25 | 2013-06-12 | 西安电子科技大学 | 对称五甲川菁染料及其在分子影像中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN112940520B (zh) | 2023-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6606096B2 (ja) | アゼチジン−置換蛍光化合物 | |
Zhang et al. | A ratiometric lysosomal pH probe based on the coumarin–rhodamine FRET system | |
Li et al. | Benzimidazole-BODIPY as optical and fluorometric pH sensor | |
CN103087545B (zh) | 一类以荧光素为母体的荧光染料、其制备方法及应用 | |
CN110272431B (zh) | 一种溶酶体靶向的光控荧光分子开关及其合成方法和应用 | |
Chen et al. | The fluorescent biomarkers for lipid droplets with quinolone-coumarin unit | |
Qu et al. | Molecular rotor based on dipyridylphenylamine: Near-infrared enhancement emission from restriction of molecular rotation and applications in viscometer and bioprobe | |
US20240353433A1 (en) | Amino-substituted chromenoquinoline-based fluorescent marker, and preparation and use thereof | |
Ni et al. | Convenient construction of fluorescent markers for lipid droplets with 1, 8-naphthalimide unit | |
Chen et al. | Rhodamine Fluorophores for STED Super‐Resolution Biological Imaging | |
CN111333619B (zh) | 一类488nm激发的高稳定性超分辨荧光染料及其合成和应用 | |
Kwon et al. | Indolizino [3, 2-c] quinolines as environment-sensitive fluorescent light-up probes for targeted live cell imaging | |
Song et al. | Self-Assembled Micellar Nanosensor toward pH with high photo-stability and its application in living cells | |
CN112940520B (zh) | 一类具有细胞器定位性质的荧光染料在细胞器成像中的应用 | |
CN111334076B (zh) | 一类高亮度、高光稳定性的细胞核荧光探针 | |
CN112945911A (zh) | 一种具有分子内开关的荧光染料在超分辨成像中的应用 | |
CN111333646B (zh) | 一种高亮度、高稳定性免洗SNAP-tag探针及其制备方法及应用 | |
CN111334077B (zh) | 一种488nm激发的高亮度、高稳定性荧光染料及其合成方法 | |
CN115991696A (zh) | 一种聚集诱导发光荧光染料MG-Rho及其制备方法和应用 | |
CN112940521B (zh) | 一类光稳定的荧光染料及其合成方法与应用 | |
CN111333574B (zh) | 一类高亮度、高光稳定性的碳酸酐酶检测荧光探针 | |
Yu et al. | Two–photon excitable red fluorophores for imaging living cells | |
Xu et al. | Photoswitchable spiropyran molecules for specific sensing of thiols and fluorescent inks | |
CN111334074A (zh) | 一种高亮度、高稳定性线粒体荧光染料 | |
CN111334084B (zh) | 一种高亮度、高稳定性、高渗透性线粒体荧光染料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |